← Back to Search

Behavioral Intervention

Cognitive Behavioral Therapy for Alcohol Use Disorder in HIV (TALC Trial)

N/A
Recruiting
Led By Karen Cropsey, Psy.D.
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Be older than 18 years old
Must not have
Active suicidality or psychosis
Inability to use a mobile phone due to cognitive or physical impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial will test if a cognitive-behavioral intervention can help people with HIV who struggle with unhealthy alcohol use and comorbid mental health symptoms.

Who is the study for?
This trial is for adults over 18 living with HIV in Alabama who drink alcohol at levels considered unhealthy. They must be getting care at certain clinics and able to use a mobile phone. People with active suicidal thoughts, psychosis, risk of severe alcohol withdrawal, or those who can't speak English well enough for therapy are not eligible.Check my eligibility
What is being tested?
The study tests if adding cognitive-behavioral therapy (CETA) via telemedicine to a brief intervention helps reduce unhealthy alcohol use and improve mental health and HIV outcomes better than the brief intervention alone.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, typical drug side effects are not expected. However, participants may experience discomfort discussing personal issues during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not currently experiencing thoughts of suicide or psychosis.
Select...
I cannot use a mobile phone because of cognitive or physical issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Alcohol Use at 6 months
Secondary outcome measures
Change from Baseline Anxiety at 12 months
Change from Baseline Anxiety at 6 months
Change from Baseline Depression at 12 months
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Common Elements Treatment Approach (CETA) via TelemedicineExperimental Treatment2 Interventions
Participants will be provided with 6 to 12 weekly CETA sessions via telephone.
Group II: Alcohol Brief Intervention (BI)Active Control1 Intervention
At the time of trial enrollment, participants will receive a session of alcohol brief intervention (BI) via telephone.

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
815 Previous Clinical Trials
1,159,563 Total Patients Enrolled
429 Trials studying Alcoholism
778,299 Patients Enrolled for Alcoholism
University of Alabama at BirminghamLead Sponsor
1,599 Previous Clinical Trials
2,287,612 Total Patients Enrolled
3 Trials studying Alcoholism
1,174 Patients Enrolled for Alcoholism
Karen Cropsey, Psy.D.Principal InvestigatorUniversity of Alabama at Birmingham
1 Previous Clinical Trials
4 Total Patients Enrolled

Media Library

Common Elements Treatment Approach (CETA) via Telemedicine (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04955795 — N/A
Alcoholism Research Study Groups: Alcohol Brief Intervention (BI), Common Elements Treatment Approach (CETA) via Telemedicine
Alcoholism Clinical Trial 2023: Common Elements Treatment Approach (CETA) via Telemedicine Highlights & Side Effects. Trial Name: NCT04955795 — N/A
Common Elements Treatment Approach (CETA) via Telemedicine (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04955795 — N/A
~200 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top